Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer.
Bissett D, O'Byrne KJ, von Pawel J, Gatzemeier U, Price A, Nicolson M, Mercier R, Mazabel E, Penning C, Zhang MH, Collier MA, Shepherd FA.
Bissett D, et al.
J Clin Oncol. 2005 Feb 1;23(4):842-9. doi: 10.1200/JCO.2005.03.170.
J Clin Oncol. 2005.
PMID: 15681529
Clinical Trial.